Table 3 Clinical characteristics, use of therapeutic procedures and hospital outcomes after matching by age and myocardial infarction type (ICD 10) for men and women hospitalized with NSTEMI according to the presence of T2DM

NSTEMI, n (%)

16,283

16,283

NA

8202

8202

NA

Age, mean (SD)

70.90 (11.05)

70.90 (11.05)

NA

76.93 (10.33)

76.93 (10.33)

NA

CCI, mean (SD)

0.61 (0.59)

0.86 (0.80)

< 0.001

0.60 (0.52)

0.83 (0.80)

< 0.001

Obesity, n (%)

1723 (10.58)

2535 (15.57)

< 0.001

993 (12.11)

1767 (21.54)

< 0.001

Hypertension, n (%)

7640 (46.92)

9291 (57.06)

< 0.001

441 (53.86)

4695 (57.24)

< 0.001

Lipid metabolism disorders, n (%)

7509 (46.12)

10,110 (62.09)

< 0.001

3754 (45.77)

4944 (60.28)

< 0.001

Renal disease, n (%)

1972 (12.11)

3430 (21.06)

< 0.001

1009 (12.30)

1877 (22.88)

< 0.001

Atrial fibrillation, n (%)

2559 (15.72)

2517 (15.46)

0.521

1724 (21.13)

1646 (20.07)

0.064

Congestive heart failure, n (%)

2460 (15.11)

3526 (21.65)

< 0.001

1682 (20.51)

2323 (28.32)

< 0.001

Peripheral vascular disease, n (%)

1357 (8.33)

2217 (13.62)

< 0.001

311 (3.79)

548 (6.68)

< 0.001

Cerebrovascular disease, n (%)

616 (3.78)

909 (5.58)

< 0.001

354 (4.32)

487 (5.94)

< 0.001

Dementia, n (%)

209 (1.28)

215 (1.32)

0.769

286 (3.49)

288 (3.51)

0.932

Mechanical ventilation, n (%)

586 (3.60)

829 (5.09)

< 0.001

270 (3.29)

389 (4.74)

< 0.001

CABG, n (%)

615 (3.78)

739 (4.54)

0.001

115 (1.40)

209 (2.55)

< 0.001

PCI, n (%)

7552 (46.38)

6982 (42.88)

< 0.001

2719 (33.15)

2715 (33.10)

0.947

LOHS, median (IQR)

5.00 (5.00)

6.00 (6.00)

< 0.001

6.00 (6.00)

6.00 (6.00)

0.89

In-hospital mortality, n (%)

706 (4.34)

790 (4.85)

0.026

523 (6.38)

601 (7.33)

0.016